Companion and Point-of-Care Sensor System for Rapid Multiplexed Detection of a Panel of Infectious Disease Markers

SLAS Technology
Anjan Panneer Selvam, Shalini Prasad

Abstract

A nanochannel-based electrochemical biosensor has been demonstrated for rapid and multiplexed detection of a panel of three biomarkers associated with rapid detection of sepsis. The label-free biosensor detected procalcitonin (PCT), lipoteichoic acid (LTA), and lipopolysaccharide (LPS) from human whole blood. The biosensor comprises a nanoporous nylon membrane integrated onto a microelectrode sensor platform for nanoconfinement effects. Charge perturbations due to biomarker binding are recorded as impedance changes using electrochemical impedance spectroscopy. The measured impedance change is used to quantitatively determine the concentration of the three biomarkers using antibody receptors from the tested sample. We were successful in detecting and quantifying the three biomarkers from whole blood. The limit of detection was 0.1 ng/mL for PCT and 1 µg/mL for LPS and LTA. The sensor was able to demonstrate a dynamic range of detection from 01.1 ng/mL to 10 µg/mL for PCT and from 1 µg/mL to 1000 µg/mL for LPS and LTA biomarkers. This novel technology has promising preliminary results toward the design of sensors for rapid and sensitive detection of the three panel biomarkers in whole blood toward diagnosis and classification of ...Continue Reading

References

Mar 10, 2001·Clinical Pharmacology and Therapeutics·UNKNOWN Biomarkers Definitions Working Group.
May 7, 2002·The American Journal of Emergency Medicine·Hakan GuvenYuksel Bek
Mar 6, 2003·Critical Care : the Official Journal of the Critical Care Forum·Canan BalcIBünyamin Kaptanoglu
Jun 10, 2003·Critical Care Medicine·Aldo LuzzaniAlberto Merlini
Jul 25, 2003·Biochimica Et Biophysica Acta·Damien Hall, Allen P Minton
Oct 16, 2004·Journal of Critical Care·Evangelos J Giamarellos-BourboulisHelen Giamarellou
Apr 25, 2006·Current Biology : CB·Allen P Minton
Feb 24, 2007·The Lancet Infectious Diseases·Benjamin M P TangAnthony S McLean
Oct 27, 2007·BMJ : British Medical Journal·Andrew Lever, Iain Mackenzie
Apr 17, 2008·Analytical and Bioanalytical Chemistry·F Lisdat, D Schäfer
May 13, 2008·The Journal of Infection·Ping-bo XuWei-dong Zhang
Jun 17, 2008·Critical Care Medicine·Yasser SakrFrank Brunkhorst
Jun 3, 2009·Critical Care Medicine·John C MarshallUNKNOWN International Sepsis Forum
Aug 1, 2009·Clinical Chemistry and Laboratory Medicine : CCLM·Johannes J M L Hoffmann
Feb 2, 2010·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Matthieu LegrandCan Ince
Oct 5, 2012·Clinical Microbiology Reviews·Konrad ReinhartChristiane S Hartog
Oct 16, 2012·International Journal of Legal Medicine·Marc AugsburgerCristian Palmiere
Jan 17, 2014·British Journal of Anaesthesia·R D GrangeD G Lambert
Mar 29, 2014·European Journal of Microbiology & Immunology·O LiesenfeldG Kost
Jan 27, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Thomas W BarrettShalini Prasad
Jun 30, 2016·EBioMedicine·I Martin Sheldon

❮ Previous
Next ❯

Citations

May 19, 2017·SLAS Technology·Dean Ho, Ali Zarrinpar
Nov 3, 2017·SLAS Technology·Hunter StevensonShalini Prasad
Mar 3, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Brandon K Ashley, Umer Hassan

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA
biosensors
biosensing
biosensor

Software Mentioned

SeptiFast
SespiTest

Related Concepts

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.